This lack of association between MYC target genes and BCR signaling in RT suggests that MYC may support CLL cell survival via alternative cellular programs, distinct from traditional BCR-mediated mechanisms. This evidence concerns the gene MYC and B-cell chronic lymphocytic leukemia.